Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma

International Journal of Oncology

Volumn 34, Issue 3, 2009, Pages 767-775

  Akagi, Ichiro ^a   Miyashita, Masao ^a   Makino, Hiroshi ^a   Nomura, Tsutomu ^a   Hagiwara, Nobutoshi ^a   Takahashi, Ken ^a   Cho, Kazumitsu ^a   Mishima, Takuya ^a   Ishibashi, Osamu ^a   Ushijima, Toshikazu ^b   Takizawa, Toshihiro ^a   Tajiri, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Immunohistochemistry; Lymph node metastasis; Phosphatidylinositol 3 kinase; PIK3CA; RT PCR

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE NUMBER; GENE OVEREXPRESSION; GENETIC GAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 64549158092     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000202     Document Type: Article

References (45)

1. Gebhart E and Liehr T: Patterns of genomic imbalances in human solid tumors (Review). Int J Oncol 16: 383-399, 2000.
2. Shinomiya T, Mori T, Ariyama Y, et al: Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer 24: 337-344, 1999.
3. Yen CC, Chen YJ, Chen JT, et al: Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 92: 2769-2777, 2001.
4. Tada K, Oka M, Tangoku A, Hayashi H, Oga A and Sasaki K: Gains of 8q23-qter and 20q and loss of 11q22-qter in esophageal squamous cell carcinoma associated with lymph node metastasis. Cancer 88: 268-273, 2000.
5. Pack SD, Karkera JD, Zhuang Z, et al: Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 25: 160-168, 1999.
6. Noguchi T, Kimura Y, Takeno S, et al: Chromosomal imbalance in esophageal squamous cell carcinoma: 3q gain correlates with tumor progression but not prognostic significance. Oncol Rep 10: 1393-1400, 2003.
7. Volinia S, Hiles I, Ormondroyd E, et al: Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene. Genomics 24: 472-477, 1994.
8. Racz A, Brass N, Heckel D, Pahl S, Remberger K and Meese E: Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 35: 641-646, 1999.
9. Shayesteh L, Lu Y, Kuo WL, et al: PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21: 99-102, 1999.
10. Ma YY, Wei SJ, Lin YC, et al: PIK3CA as an oncogene in cervical cancer. Oncogene 19: 2739-2744, 2000.
11. Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J and du Manoir S A: Simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61: 4122-4129, 2001.
12. Vivanco I and Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
13. Klippel A, Escobedo MA, Wachowicz MS, et al: Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 18: 5699-5711, 1998.
14. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH and Downward J: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793, 1997.
15. Kennedy SG, Wagner AJ, Conzen SD, et al: The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11: 701-713, 1997.
16. Frevert EU and Kahn BB: Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 17: 190-198, 1997.
17. Cantley LC: The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
18. Guo XN, Rajput A, Rose R, et al: Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. Cancer Res 67: 5851-5858, 2007.
19. Ikenoue T, Kanai F, Hikiba Y, et al: Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65: 4562-4567, 2005.
20. Kang S, Bader AG and Vogt PK: Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102: 802-807, 2005.
21. Bader AG, Kang S and Vogt PK: Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 103: 1475-1479, 2006.
22. Phillips WA, Russell SE, Ciavarella ML, et al: Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. Int J Cancer 118: 2644-2646, 2006.
23. Fenic I, Steger K, Gruber C, Arens C and Woenckhaus J: Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Oncol Rep 18: 253-259, 2007.
24. Kim TJ, Lee JW, Song SY, et al: Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer 94: 1678-1682, 2006.
25. Li VS, Wong CW, Chan TL, et al: Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 5: 29, 2005.
26. Broderick DK, Di C, Parrett TJ, et al: Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64: 5048-5050, 2004.
27. Samuels Y, Wang Z, Bardelli A, et al: High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554, 2004.
28. Samuels Y and Velculescu VE: Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3: 1221-1224, 2004.
29. Bachman KE, Argani P, Samuels Y, et al: The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3: 772-775, 2004.
30. Campbell IG, Russell SE, Choong DY, et al: Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64: 7678-7681, 2004.
31. Levine DA, Bogomolniy F, Yee CJ, et al: Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 11: 2875-2878, 2005.
32. Lee JW, Soung YH, Kim SY, et al: PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24: 1477-1480, 2005.
33. Wang Y, Helland A, Holm R, Kristensen GB and Borresen-Dale AL: PIK3CA mutations in advanced ovarian carcinomas. Hum Mutat 25: 322, 2005.
34. Hartmann C, Bartels G, Gehlhaar C, Holtkamp N and von Deimling A: PIK3CA mutations in glioblastoma multiforme. Acta Neuropathol (Berl) 109: 639-642, 2005.
35. Qiu W, Schonleben F, Li X, et al: PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res 12: 1441-1446, 2006.
36. Kozaki K, Imoto I, Pimkhaokham A, et al: PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma. Cancer Sci 97: 1351-1358, 2006.
37. Yen CC, Chen YJ, Pan CC, et al: Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed. World J Gastroenterol 11: 1267-1272, 2005.
38. Pedrero JM, Carracedo DG, Pinto CM, et al: Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer 114: 242-248, 2005.
39. Imoto I, Pimkhaokham A, Fukuda Y, et al: SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 286: 559-565, 2001.
40. Woenckhaus J, Steger K, Werner E, et al: Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198: 335-342, 2002.
41. Woenckhaus J, Steger K, Sturm K, Munstedt K, Franke FE and Fenic I: Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. Virchows Arch 450: 387-395, 2007.
42. Singh B, Reddy PG, Goberdhan A, et al: p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 16: 984-993, 2002.
43. Wada S, Noguchi T, Takeno S and Kawahara K: PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Ann Surg Oncol 13: 961-966, 2006.
44. Lin X, Bohle AS, Dohrmann P, et al: Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbecks Arch Surg 386: 293-301, 2001.
45. Saal LH, Holm K, Maurer M, et al: PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 65: 2554-2559, 2005.